[Form 4] Xometry, Inc. Insider Trading Activity
Emily Rollins, a director of Xometry, Inc. (XMTR), executed stock-option transactions on 08/11/2025. The filing shows the exercise/conversion of a stock option with an exercise price of $12.32 to acquire 350 shares of Class A common stock, increasing her direct beneficial ownership to 11,455 shares. Table II lists the option details (exercise price $12.32; 350 options; expiration 02/24/2031) and notes the options are fully vested.
The Form 4 was signed by Kristie Scott as attorney-in-fact on 08/12/2025 and filed as a Form 4 reporting transaction code M. No amendments or other transactions are reported in the provided content.
- Director acquired 350 shares through a reported option exercise, an explicit, disclosed insider transaction.
- Options were fully vested, as stated in the filing, removing vesting contingency for the reported exercise.
- None.
Insights
TL;DR: Routine insider option exercise—350 shares acquired at $12.32; disclosure appears standard and not materially dilutive.
The filing documents a director-level exercise of 350 stock options on 08/11/2025 at an exercise/conversion price of $12.32, resulting in 11,455 shares beneficially owned directly. The options are noted as fully vested and the form was executed by an attorney-in-fact. This is a standard Section 16 disclosure of a director option exercise with no other compensatory or unusual terms disclosed in the document.
TL;DR: Director exercise and standard Form 4 filing; fully vested options recorded and signed by attorney-in-fact.
The record shows routine reporting compliance: a director exercised options to acquire 350 Class A shares, exercise price $12.32, with the derivative details and expiration date (02/24/2031) included and a note that the options are fully vested. The Form 4 is signed by an attorney-in-fact on 08/12/2025. Based on the data in this filing alone, the disclosure meets standard insider reporting requirements and contains no additional governance concerns.